The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Oncolytic polio/rhinovirus recombinant (PVSRIPO) against recurrent glioblastoma (GBM): Optimal dose determination.
 
Annick Desjardins
Consulting or Advisory Role - Celldex; EMD Serono; Genentech; Lilly
Patents, Royalties, Other Intellectual Property - Letters Patents for Oncolytic Poliovirus for Human Tumors; Letters Patents for Oncolytic Poliovirus for Human Tumors (Inst)
 
John H. Sampson
Patents, Royalties, Other Intellectual Property - letters Patent for Oncolytic Poliovirus for Human Tumors; letters Patent for Oncolytic Poliovirus for Human Tumors (Inst)
 
Katherine B. Peters
No Relationships to Disclose
 
Gordana Vlahovic
No Relationships to Disclose
 
Dina Randazzo
No Relationships to Disclose
 
Stevie Threatt
No Relationships to Disclose
 
James Emmett Herndon
No Relationships to Disclose
 
Susan Boulton
No Relationships to Disclose
 
Denise Lally-Goss
No Relationships to Disclose
 
Frances McSherry
No Relationships to Disclose
 
Eric S Lipp
No Relationships to Disclose
 
Allan H. Friedman
No Relationships to Disclose
 
Henry S. Friedman
Patents, Royalties, Other Intellectual Property - Letters Patents for Oncolytic Poliovirus for Human Tumors; Letters Patents for Oncolytic Poliovirus for Human Tumors (Inst)
 
Darell D. Bigner
Patents, Royalties, Other Intellectual Property - Letters Patents for Oncolytic Poliovirus for Human Tumors; Letters Patents for Oncolytic Poliovirus for Human Tumors (Inst)
 
Matthias Gromeier
Patents, Royalties, Other Intellectual Property - letters Patent for Oncolytic Poliovirus for Human Tumors; letters Patent for Oncolytic Poliovirus for Human Tumors (Inst)